Yamashita, Y., Y. Hori, H. Kosako, T. Oiwa, K. Warigaya, T. Mushino, S. Murata, M. Fujimoto, A. Nishikawa, S.- ichi Murata, T. Sonoki, and S. Tamura. “Brentuximab Vedotin for Refractory Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma in Leukemic Phase With <em>RUNX3</em&gt; Overexpression”. Hematology Reports, Vol. 12, no. 1, May 2020, doi:10.4081/hr.2020.8368.